Technology | 2013.05.23
Agilent Technologies, University of Rouen and A*STAR’s Bioprocessing Technology Institute to Further Innovation in Biopharmaceuticals and Glycomics
SANTA CLARA, Calif. & ROUEN, France & SINGAPORE--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A), the Glyco-MEV laboratory at the University of Rouen, in France, and the Bioprocessing Technology Institute at the Agency for Science, Technology and Research (A*STAR), in Singapore, have signed a memorandum of understanding to work together in order to develop tools to effectively analyze biologics and vaccines. Biologics are molecules such as antibodies and other recombinant protein-based ther
For more information, please visit
http://www.businesswire.com/news/home/20[...]0%99s-Bioprocessing-Technology
